chrX-110198594-G-A

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_015365.3(AMMECR1):​c.928C>T​(p.Leu310Phe) variant causes a missense change. The variant allele was found at a frequency of 0.00000183 in 1,090,803 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 23)
Exomes 𝑓: 0.0000018 ( 0 hom. 0 hem. )

Consequence

AMMECR1
NM_015365.3 missense

Scores

8
9

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.87

Publications

0 publications found
Variant links:
Genes affected
AMMECR1 (HGNC:467): (AMMECR nuclear protein 1) The exact function of this gene is not known, however, submicroscopic deletion of the X chromosome including this gene, COL4A5, and FACL4 genes, result in a contiguous gene deletion syndrome, the AMME complex (Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2010]
AMMECR1 Gene-Disease associations (from GenCC):
  • midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis
    Inheritance: XL Classification: STRONG, MODERATE Submitted by: Illumina, Labcorp Genetics (formerly Invitae)
  • Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.3250437).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AMMECR1NM_015365.3 linkc.928C>T p.Leu310Phe missense_variant Exon 6 of 6 ENST00000262844.10 NP_056180.1
AMMECR1NM_001025580.2 linkc.817C>T p.Leu273Phe missense_variant Exon 5 of 5 NP_001020751.1
AMMECR1NM_001171689.2 linkc.559C>T p.Leu187Phe missense_variant Exon 8 of 8 NP_001165160.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AMMECR1ENST00000262844.10 linkc.928C>T p.Leu310Phe missense_variant Exon 6 of 6 1 NM_015365.3 ENSP00000262844.5 Q9Y4X0-1

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD4 exome
AF:
0.00000183
AC:
2
AN:
1090803
Hom.:
0
Cov.:
28
AF XY:
0.00
AC XY:
0
AN XY:
357083
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
25968
American (AMR)
AF:
0.00
AC:
0
AN:
34368
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19101
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29887
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53026
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40379
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4094
European-Non Finnish (NFE)
AF:
0.00000239
AC:
2
AN:
838229
Other (OTH)
AF:
0.00
AC:
0
AN:
45751
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.400
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
23
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jul 05, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.928C>T (p.L310F) alteration is located in exon 6 (coding exon 6) of the AMMECR1 gene. This alteration results from a C to T substitution at nucleotide position 928, causing the leucine (L) at amino acid position 310 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.43
BayesDel_addAF
Benign
-0.028
T
BayesDel_noAF
Benign
-0.28
CADD
Uncertain
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.27
T;.;.
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.91
D;D;D
M_CAP
Uncertain
0.17
D
MetaRNN
Benign
0.33
T;T;T
MetaSVM
Uncertain
-0.24
T
MutationAssessor
Benign
2.0
M;.;.
PhyloP100
4.9
PrimateAI
Uncertain
0.77
T
PROVEAN
Benign
-1.8
N;N;N
REVEL
Uncertain
0.40
Sift
Benign
0.073
T;T;T
Sift4G
Benign
0.11
T;T;T
Polyphen
0.80
P;D;.
Vest4
0.31
MutPred
0.30
Gain of catalytic residue at L310 (P = 0.1327);.;.;
MVP
0.54
MPC
1.1
ClinPred
0.72
D
GERP RS
4.1
Varity_R
0.46
gMVP
0.84
Mutation Taster
=47/53
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2067382571; hg19: chrX-109441822; API